美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

SPYRE THERAPEUTICS INC

24.36

+0.86003.66%

盤後：24.720.3600+1.48%16:50 EST

成交量：72.32萬

成交額：1,764.87萬

市值：18.90億

市盈率：-12.16

高：25.02

開：23.47

低：23.03

收：23.50

52周最高：31.35

52周最低：10.91

股本：7,759.21萬

流通股本：6,382.98萬

量比：1.38

換手率：1.13%

股息：- -

股息率：- -

每股收益(TTM):-2.0036

每股收益(LYR):-3.1802

淨資產收益率：-38.08%

總資產收益率：-30.20%

市淨率：6.32

市盈率(LYR):-7.66

資料載入中...

總覽公司新聞資訊公告

Spyre Therapeutics - Spy003顯示約85天的半衰期，支持每季度或每年兩次的維持劑量

Spyre Therapeutics：Spy003在所有劑量水平上耐受良好，安全性特徵符合抗IL-23類藥物

Spyre Therapeutics發佈Spy003的積極中期I期結果，這是一種新型半衰期延長的抗IL-23抗體

嗡嗡聲--美國股票走勢-Spyre Therapeutics、Astria、沃爾瑪

SPYRE THERAPEUTICS INC預計截至2025年9月30日現金及等價物為4.862億美元

BUZZ-Spyre Therapeutics 股票發行後下跌

Spyre Therapeutics宣佈授予員工股票期權激勵獎勵

美國研究綜述-Carmax、Mirion Technologies、Valmont Industries

美國研究綜述-Carmax、Mirion Technologies、Valmont Industries

Spyre Therapeutics在開創性2期Skyway籃式試驗中為首位患者給藥，Spy072成為首個在風濕性疾病中研究的抗Tl1a抗體

Spyre Therapeutics, Inc.2025財年第二財季實現淨利潤-36.72百萬美元，同比減少37.27%

IBM推出新芯片和服務器，主打為業務運營簡化人工智能流程

美國研究綜述-美國航空公司、捷普公司、萊納公司

Spyre Therapeutics, Inc.2025財年第一財季實現淨利潤-36.09百萬美元，同比減少36.65%

Spyre Therapeutics, Inc.盤中異動股價大漲5.12%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SYRE/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SYRE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SYRE\",,,,,undefined,":{"symbol":"SYRE","market":"US","secType":"STK","nameCN":"SPYRE THERAPEUTICS INC","latestPrice":24.36,"timestamp":1763413200000,"preClose":23.5,"halted":0,"volume":723162,"hourTrading":{"tag":"盘后","latestPrice":24.72,"preClose":24.36,"latestTime":"16:50 EST","volume":14479,"amount":352709.52592499997,"timestamp":1763416239596},"delay":0,"floatShares":63829799,"shares":77592130,"eps":-2.003614,"marketStatus":"盤後交易","change":0.86,"latestTime":"11-17 18:00:18 EST","open":23.47,"high":25.02,"low":23.03,"amount":17648665.920996,"amplitude":0.084681,"askPrice":25.23,"askSize":5,"bidPrice":21.56,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.003614,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1763427600000},"marketStatusCode":4,"adr":0,"listingDate":1460001600000,"exchange":"NASDAQ","adjPreClose":23.5,"preHourTrading":{"tag":"盘前","latestPrice":23.55,"preClose":23.5,"latestTime":"09:09 EST","volume":2355,"amount":55438.138905,"timestamp":1763388573309},"postHourTrading":{"tag":"盘后","latestPrice":24.72,"preClose":24.36,"latestTime":"16:50 EST","volume":14479,"amount":352709.52592499997,"timestamp":1763416239596},"volumeRatio":1.380065,"impliedVol":0.6469,"impliedVolPercentile":0.476},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SYRE\",,,,,undefined,":{"symbol":"SYRE","floatShares":63829799,"roa":"-30.20%","roe":"-38.08%","lyrEps":-3.180151,"volumeRatio":1.380065,"shares":77592130,"dividePrice":0,"high":25.02,"amplitude":0.084681,"preClose":23.5,"low":23.03,"week52Low":10.91,"pbRate":"6.32","week52High":31.35,"institutionHeld":0,"latestPrice":24.36,"committee":0.904762,"eps":-2.003614,"divideRate":0,"volume":723162,"delay":0,"ttmEps":-2.003614,"open":23.47,"prevYearClose":23.28,"prevWeekClose":23.5,"prevMonthClose":24.46,"prevQuarterClose":16.76,"fiveDayClose":22.18,"twentyDayClose":23.49,"sixtyDayClose":17.38},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SYRE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-04","symbol":"SYRE","fiscalQuarterEnding":"2025/09","expectedEps":-0.68,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2025-08-05","symbol":"SYRE","fiscalQuarterEnding":"2025/06","expectedEps":-0.73,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-05-08","symbol":"SYRE","fiscalQuarterEnding":"2025/03","expectedEps":-0.76,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.74},{"market":"US","date":"2025-02-27","symbol":"SYRE","fiscalQuarterEnding":"2024/12","expectedEps":-1.1,"name":null,"time":"盤後","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.81},{"market":"US","date":"2024-11-07","symbol":"SYRE","fiscalQuarterEnding":"2024/09","expectedEps":-0.8,"name":null,"time":"盤後","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-1.36}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SYRE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SYRE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6154,"buy":0.3077,"hold":0.0769,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6154,"analysts":13,"updateTime":1758949200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SYRE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SYRE","date":"2025-11-14","current":-12.018283,"percent":0.008163,"low":-12.203771,"twenty":-6.900444,"median":-4.731283,"eighty":-3.707046,"high":-0.199399,"avg":-5.226357,"sd":2.003242,"marketCap":1755909901},"quantilePoints":[{"date":"2023-12-01","current":-1.902619,"twenty":-1.228042,"median":-0.216176,"eighty":-0.20611,"marketCap":560191990},{"date":"2023-12-08","current":-2.024974,"twenty":-2.048834,"median":-1.98164,"eighty":-0.890753,"marketCap":596217199},{"date":"2023-12-15","current":-1.815535,"twenty":-2.023412,"median":-1.966856,"eighty":-1.735642,"marketCap":534551743},{"date":"2023-12-22","current":-2.106706,"twenty":-2.023412,"median":-1.950531,"eighty":-1.82549,"marketCap":620281740},{"date":"2023-12-29","current":-2.507984,"twenty":-2.09023,"median":-1.996425,"eighty":-1.840422,"marketCap":738430643},{"date":"2024-01-05","current":-2.757559,"twenty":-2.278228,"median":-2.002935,"eighty":-1.873937,"marketCap":811913497},{"date":"2024-01-12","current":-2.567931,"twenty":-2.588728,"median":-2.024974,"eighty":-1.89995,"marketCap":756080936},{"date":"2024-01-19","current":-2.66458,"twenty":-2.653814,"median":-2.09023,"eighty":-1.902486,"marketCap":784537532},{"date":"2024-01-26","current":-3.303198,"twenty":-2.742878,"median":-2.292052,"eighty":-1.915254,"marketCap":972567189},{"date":"2024-02-02","current":-3.16373,"twenty":-3.116751,"median":-2.567931,"eighty":-1.947266,"marketCap":931503241},{"date":"2024-02-09","current":-2.89825,"twenty":-3.138772,"median":-2.61809,"eighty":-1.978684,"marketCap":853337655},{"date":"2024-02-16","current":-2.760005,"twenty":-3.112591,"median":-2.66458,"eighty":-1.997649,"marketCap":812633917},{"date":"2024-02-23","current":-2.496973,"twenty":-3.08641,"median":-2.66458,"eighty":-2.000865,"marketCap":735188752},{"date":"2024-03-01","current":-3.357028,"twenty":-3.117974,"median":-2.696389,"eighty":-2.009323,"marketCap":988416432},{"date":"2024-03-08","current":-4.14553,"twenty":-3.186241,"median":-2.748383,"eighty":-2.021849,"marketCap":1404464057},{"date":"2024-03-15","current":-4.473117,"twenty":-3.315921,"median":-2.757559,"eighty":-2.032927,"marketCap":1515447446},{"date":"2024-03-22","current":-4.253303,"twenty":-3.374155,"median":-2.84075,"eighty":-2.069838,"marketCap":1440976508},{"date":"2024-03-28","current":-3.948124,"twenty":-3.948124,"median":-2.884793,"eighty":-2.09023,"marketCap":1337584817},{"date":"2024-04-05","current":-3.822655,"twenty":-3.997689,"median":-2.933117,"eighty":-2.106706,"marketCap":1295077328},{"date":"2024-04-12","current":-4.169482,"twenty":-4.017483,"median":-2.950857,"eighty":-2.22293,"marketCap":1412578691},{"date":"2024-04-19","current":-3.844264,"twenty":-4.019298,"median":-3.071974,"eighty":-2.361175,"marketCap":1302398285},{"date":"2024-04-26","current":-3.508242,"twenty":-4.017483,"median":-3.149049,"eighty":-2.496973,"marketCap":1188557401},{"date":"2024-05-03","current":-4.312212,"twenty":-4.026871,"median":-3.180093,"eighty":-2.505537,"marketCap":1460934345},{"date":"2024-05-10","current":-4.183809,"twenty":-4.050631,"median":-3.290964,"eighty":-2.507984,"marketCap":1417432578},{"date":"2024-05-17","current":-4.180278,"twenty":-4.096445,"median":-3.334395,"eighty":-2.567931,"marketCap":1522561849},{"date":"2024-05-24","current":-3.614061,"twenty":-4.096445,"median":-3.364368,"eighty":-2.569154,"marketCap":1316331249},{"date":"2024-05-31","current":-4.872934,"twenty":-4.111605,"median":-3.38639,"eighty":-2.608303,"marketCap":1774844320},{"date":"2024-06-07","current":-4.694469,"twenty":-4.171641,"median":-3.527045,"eighty":-2.61809,"marketCap":1709842869},{"date":"2024-06-14","current":-4.393309,"twenty":-4.193693,"median":-3.59738,"eighty":-2.63375,"marketCap":1600152919},{"date":"2024-06-21","current":-3.360163,"twenty":-4.181695,"median":-3.573485,"eighty":-2.653814,"marketCap":1223855454},{"date":"2024-06-28","current":-3.277902,"twenty":-4.180281,"median":-3.545724,"eighty":-2.666048,"marketCap":1193893847},{"date":"2024-07-05","current":-3.553965,"twenty":-4.180278,"median":-3.545724,"eighty":-2.674367,"marketCap":1294442968},{"date":"2024-07-12","current":-4.13816,"twenty":-4.17596,"median":-3.564426,"eighty":-2.694186,"marketCap":1507221157},{"date":"2024-07-19","current":-4.113063,"twenty":-4.180278,"median":-3.593701,"eighty":-2.712782,"marketCap":1498080328},{"date":"2024-07-26","current":-4.387732,"twenty":-4.219183,"median":-3.614061,"eighty":-2.731867,"marketCap":1598121624},{"date":"2024-08-02","current":-3.651563,"twenty":-4.192391,"median":-3.674487,"eighty":-2.752053,"marketCap":1329990636},{"date":"2024-08-09","current":-6.773008,"twenty":-4.238871,"median":-3.689208,"eighty":-2.757559,"marketCap":1259650875},{"date":"2024-08-16","current":-7.111659,"twenty":-4.267009,"median":-3.707046,"eighty":-2.757559,"marketCap":1322633418},{"date":"2024-08-23","current":-6.972375,"twenty":-4.305721,"median":-3.744862,"eighty":-2.758537,"marketCap":1296729308},{"date":"2024-08-30","current":-7.851774,"twenty":-4.372067,"median":-3.796365,"eighty":-2.792303,"marketCap":1460280752},{"date":"2024-09-06","current":-7.655166,"twenty":-4.395693,"median":-3.839237,"eighty":-2.844176,"marketCap":1423715511},{"date":"2024-09-13","current":-8.038472,"twenty":-4.515004,"median":-3.909092,"eighty":-2.863261,"marketCap":1495003126},{"date":"2024-09-20","current":-8.260242,"twenty":-4.753435,"median":-3.923931,"eighty":-2.887484,"marketCap":1536248103},{"date":"2024-09-27","current":-7.800275,"twenty":-4.893011,"median":-3.931452,"eighty":-2.904612,"marketCap":1450702965},{"date":"2024-10-04","current":-7.980976,"twenty":-5.268067,"median":-3.990592,"eighty":-2.931282,"marketCap":1484309983},{"date":"2024-10-11","current":-7.857771,"twenty":-6.760445,"median":-4.004311,"eighty":-2.936176,"marketCap":1461396107},{"date":"2024-10-18","current":-8.969358,"twenty":-6.959266,"median":-4.01434,"eighty":-2.939112,"marketCap":1668130191},{"date":"2024-10-25","current":-9.530627,"twenty":-7.262959,"median":-4.019298,"eighty":-2.969942,"marketCap":1772515627},{"date":"2024-11-01","current":-9.303382,"twenty":-7.505129,"median":-4.04736,"eighty":-3.046528,"marketCap":1730252255},{"date":"2024-11-08","current":-9.47125,"twenty":-7.585076,"median":-4.070861,"eighty":-3.057293,"marketCap":2035390531},{"date":"2024-11-15","current":-6.988263,"twenty":-7.603794,"median":-4.087936,"eighty":-3.101825,"marketCap":1501791624},{"date":"2024-11-22","current":-7.566995,"twenty":-7.593388,"median":-4.106049,"eighty":-3.128495,"marketCap":1626162294},{"date":"2024-11-29","current":-7.766414,"twenty":-7.602508,"median":-4.133831,"eighty":-3.149049,"marketCap":1669017834},{"date":"2024-12-06","current":-7.397625,"twenty":-7.602508,"median":-4.146835,"eighty":-3.16373,"marketCap":1589764437},{"date":"2024-12-13","current":-6.589022,"twenty":-7.597044,"median":-4.169482,"eighty":-3.166361,"marketCap":1415994026},{"date":"2024-12-20","current":-6.517996,"twenty":-7.595055,"median":-4.180278,"eighty":-3.169847,"marketCap":1400730409},{"date":"2024-12-27","current":-6.466093,"twenty":-7.588386,"median":-4.182047,"eighty":-3.186241,"marketCap":1389576227},{"date":"2025-01-03","current":-6.651853,"twenty":-7.58308,"median":-4.215671,"eighty":-3.191991,"marketCap":1429496457},{"date":"2025-01-10","current":-6.135549,"twenty":-7.579794,"median":-4.247699,"eighty":-3.203592,"marketCap":1318541701},{"date":"2025-01-17","current":-5.632904,"twenty":-7.573901,"median":-4.253955,"eighty":-3.236074,"marketCap":1210522256},{"date":"2025-01-24","current":-5.900617,"twenty":-7.564263,"median":-4.27898,"eighty":-3.264517,"marketCap":1268054352},{"date":"2025-01-31","current":-6.280332,"twenty":-7.548513,"median":-4.304099,"eighty":-3.280514,"marketCap":1349655997},{"date":"2025-02-07","current":-6.187452,"twenty":-7.528128,"median":-4.345056,"eighty":-3.293411,"marketCap":1329695883},{"date":"2025-02-14","current":-6.26121,"twenty":-7.522652,"median":-4.382852,"eighty":-3.305947,"marketCap":1345546562},{"date":"2025-02-21","current":-5.815932,"twenty":-7.518271,"median":-4.394799,"eighty":-3.316941,"marketCap":1249855423},{"date":"2025-02-28","current":-5.708297,"twenty":-7.512359,"median":-4.473117,"eighty":-3.319102,"marketCap":1187428551},{"date":"2025-03-07","current":-5.647447,"twenty":-7.483663,"median":-4.605135,"eighty":-3.349687,"marketCap":1174770683},{"date":"2025-03-14","current":-5.227293,"twenty":-7.452562,"median":-4.749486,"eighty":-3.357028,"marketCap":1087371120},{"date":"2025-03-21","current":-5.264962,"twenty":-7.449529,"median":-4.833391,"eighty":-3.360163,"marketCap":1095206943},{"date":"2025-03-28","current":-5.198317,"twenty":-7.397625,"median":-4.89803,"eighty":-3.364368,"marketCap":1081343564},{"date":"2025-04-04","current":-3.706047,"twenty":-7.375771,"median":-4.833391,"eighty":-3.376602,"marketCap":770924425},{"date":"2025-04-11","current":-3.540883,"twenty":-7.371109,"median":-4.749486,"eighty":-3.378289,"marketCap":736567355},{"date":"2025-04-17","current":-3.671275,"twenty":-7.352984,"median":-4.694469,"eighty":-3.38477,"marketCap":763691357},{"date":"2025-04-25","current":-4.094327,"twenty":-7.328784,"median":-4.51381,"eighty":-3.412624,"marketCap":851693676},{"date":"2025-05-02","current":-4.378293,"twenty":-7.296115,"median":-4.473117,"eighty":-3.422161,"marketCap":910763726},{"date":"2025-05-09","current":-4.072986,"twenty":-7.269514,"median":-4.422481,"eighty":-3.450063,"marketCap":850985210},{"date":"2025-05-16","current":-4.384959,"twenty":-7.258044,"median":-4.393309,"eighty":-3.492778,"marketCap":916167055},{"date":"2025-05-23","current":-4.353184,"twenty":-7.252035,"median":-4.386346,"eighty":-3.506946,"marketCap":909528164},{"date":"2025-05-30","current":-4.491839,"twenty":-7.242247,"median":-4.381626,"eighty":-3.527827,"marketCap":938497873},{"date":"2025-06-06","current":-4.800924,"twenty":-7.228256,"median":-4.393309,"eighty":-3.543713,"marketCap":1003076183},{"date":"2025-06-13","current":-5.115786,"twenty":-7.156112,"median":-4.413455,"eighty":-3.545748,"marketCap":1068861565},{"date":"2025-06-20","current":-4.356073,"twenty":-7.062301,"median":-4.413455,"eighty":-3.549094,"marketCap":910131699},{"date":"2025-06-27","current":-4.627605,"twenty":-6.984824,"median":-4.413846,"eighty":-3.558149,"marketCap":966864047},{"date":"2025-07-03","current":-4.5525,"twenty":-6.978207,"median":-4.413846,"eighty":-3.566238,"marketCap":951172121},{"date":"2025-07-11","current":-4.610273,"twenty":-6.959266,"median":-4.434912,"eighty":-3.576816,"marketCap":963242833},{"date":"2025-07-18","current":-4.878917,"twenty":-6.905553,"median":-4.448509,"eighty":-3.590436,"marketCap":1019371645},{"date":"2025-07-25","current":-5.084011,"twenty":-6.899536,"median":-4.462257,"eighty":-3.592447,"marketCap":1062222673},{"date":"2025-08-01","current":-4.902026,"twenty":-6.889009,"median":-4.488402,"eighty":-3.59611,"marketCap":1024199930},{"date":"2025-08-08","current":-4.450911,"twenty":-6.843738,"median":-4.500505,"eighty":-3.597671,"marketCap":920510630},{"date":"2025-08-15","current":-4.924039,"twenty":-6.770823,"median":-4.509171,"eighty":-3.60188,"marketCap":1018360185},{"date":"2025-08-22","current":-4.900675,"twenty":-6.760445,"median":-4.52404,"eighty":-3.616232,"marketCap":1013528108},{"date":"2025-08-29","current":-4.883151,"twenty":-6.744059,"median":-4.5525,"eighty":-3.624946,"marketCap":1009904051},{"date":"2025-09-05","current":-4.962006,"twenty":-6.704732,"median":-4.610273,"eighty":-3.625072,"marketCap":1026212310},{"date":"2025-09-12","current":-4.731283,"twenty":-6.670975,"median":-4.650968,"eighty":-3.630649,"marketCap":978495552},{"date":"2025-09-19","current":-4.474275,"twenty":-6.670975,"median":-4.610273,"eighty":-3.651563,"marketCap":925342707},{"date":"2025-09-26","current":-4.558971,"twenty":-6.651853,"median":-4.590463,"eighty":-3.659766,"marketCap":942858985},{"date":"2025-10-03","current":-4.667031,"twenty":-6.651853,"median":-4.640746,"eighty":-3.671275,"marketCap":965207340},{"date":"2025-10-10","current":-6.182794,"twenty":-6.639187,"median":-4.66411,"eighty":-3.682866,"marketCap":1278688323},{"date":"2025-10-17","current":-6.495292,"twenty":-6.589022,"median":-4.675298,"eighty":-3.682866,"marketCap":1343317350},{"date":"2025-10-24","current":-8.382293,"twenty":-6.651853,"median":-4.679157,"eighty":-3.689208,"marketCap":1733575542},{"date":"2025-10-31","current":-9.090497,"twenty":-6.704732,"median":-4.696933,"eighty":-3.700564,"marketCap":1880042140},{"date":"2025-11-07","current":-11.662076,"twenty":-6.790267,"median":-4.714264,"eighty":-3.706047,"marketCap":1737287790},{"date":"2025-11-14","current":-11.787083,"twenty":-6.900444,"median":-4.731283,"eighty":-3.707046,"marketCap":1755909901}],"updateTime":1763396050814},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SYRE\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1177535994","title":"Spyre Therapeutics - Spy003顯示約85天的半衰期，支持每季度或每年兩次的維持劑量","url":"https://stock-news.laohu8.com/highlight/detail?id=1177535994","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177535994?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 05:40","pubTimestamp":1762292412,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics - Spy003显示约85天的半衰期，支持每季度或每年两次的维持剂量","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SYRE"],"gpt_icon":0},{"id":"1173012956","title":"Spyre Therapeutics：Spy003在所有劑量水平上耐受良好，安全性特徵符合抗IL-23類藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=1173012956","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173012956?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 05:40","pubTimestamp":1762292408,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics：Spy003在所有剂量水平上耐受良好，安全性特征符合抗IL-23类药物","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE","BK4139"],"gpt_icon":0},{"id":"1132251468","title":"Spyre Therapeutics發佈Spy003的積極中期I期結果，這是一種新型半衰期延長的抗IL-23抗體","url":"https://stock-news.laohu8.com/highlight/detail?id=1132251468","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132251468?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 05:02","pubTimestamp":1762290128,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics发布Spy003的积极中期I期结果，这是一种新型半衰期延长的抗IL-23抗体","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE","BK4139"],"gpt_icon":0},{"id":"2575217706","title":"嗡嗡聲--美國股票走勢-Spyre Therapeutics、Astria、沃爾瑪","url":"https://stock-news.laohu8.com/highlight/detail?id=2575217706","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575217706?lang=zh_tw&edition=fundamental","pubTime":"2025-10-14 23:55","pubTimestamp":1760457357,"startTime":"0","endTime":"0","summary":"nL3N3VV0MP ** Spyre Therapeutics Inc SYRE.O:BUZZ - 募集 2.75 亿美元股本后股价上涨   nL6N3VV0QB ** CNX Resources Corp link) >：** EQT Corp EQT.N：** Energy Transfer LP ET.N：** NextDecade Corp link) >：BUZZ - 天然气公司因天气温和、需求预测减弱而下跌   nL3N3VV1BA ** 惠普公司HPQ.N：BUZZ--汇丰银行将惠普的评级提升至 \"买入\"，原因是个人电脑销售势头改善。nL6N3VV0PD ** Astria Therapeutics Inc ATXS.O:BUZZ - 因BioCryst达成7亿美元收购交易而大涨   nL3N3VV18T ** Fastenal Co FAST.O:BUZZ - 巴克莱下调Fastenal第三季度利润预期，低于预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nL3T3VV1G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APA","OEC","PMAX","GM","EQT","ANRO","CNX","ANET","SNTI","AQMS","FAST","GWAV","AKA","NVAX","RYN","3NVD.UK","NVIW.SI","MGM","NEXT","PCH","EDHL","WMT","ET","2NVD.UK","DLTR","WAB","DPZ","HPQ","EXPD","HUM","ATXS","ACI","CVX","XOM","BLK","PAVS","JNJ","PTRN","SYRE","BCRX","PII","DE"],"gpt_icon":1},{"id":"1188563637","title":"SPYRE THERAPEUTICS INC預計截至2025年9月30日現金及等價物為4.862億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1188563637","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188563637?lang=zh_tw&edition=fundamental","pubTime":"2025-10-14 18:27","pubTimestamp":1760437631,"startTime":"0","endTime":"0","summary":"SPYRE THERAPEUTICS INC预计截至2025年9月30日现金及等价物为4.862亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE","BK4139"],"gpt_icon":0},{"id":"2575102280","title":"BUZZ-Spyre Therapeutics 股票發行後下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2575102280","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575102280?lang=zh_tw&edition=fundamental","pubTime":"2025-10-14 04:17","pubTimestamp":1760386641,"startTime":"0","endTime":"0","summary":"BUZZ-Spyre Therapeutics 股票发行后下跌10月13日 - ** Spyre Therapeutics SYRE.O股价盘后下跌5.1%至17.96美元，原因是该公司正在寻求股权融资** 总部位于马萨诸塞州沃尔瑟姆、专注于治疗炎症性肠病和其他免疫介导疾病的生物技术公司开始  发行股票和预筹认股权证，但未披露目标交易规模** Jefferies、TD Secs、Leerink 和 Stifel 为联合账簿管理人** 公司拥有约 6040 万股流通股，市值约为 11 亿美元** SYRE 股价周一下跌 1.2%，收于 18.92 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nL3T3VU17M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","JEF","BK4559","SYRE","BK4139"],"gpt_icon":0},{"id":"1195222682","title":"Spyre Therapeutics宣佈授予員工股票期權激勵獎勵","url":"https://stock-news.laohu8.com/highlight/detail?id=1195222682","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195222682?lang=zh_tw&edition=fundamental","pubTime":"2025-10-04 04:08","pubTimestamp":1759522131,"startTime":"0","endTime":"0","summary":"马萨诸塞州沃尔瑟姆，2025年10月3日——临床阶段生物技术公司Spyre Therapeutics, Inc.今日宣布，公司独立董事会薪酬委员会批准向三名非执行员工授予总计42,500股普通股的股票期权，作为根据经修订的《Spyre Therapeutics, Inc. 2018年股权激励计划》项下的股权激励奖励。Spyre Therapeutics是一家临床阶段生物技术公司，致力于通过结合一流的抗体工程、剂量优化和合理的治疗组合，开发下一代炎症性肠病和其他免疫介导疾病产品。Spyre的产品管线包括针对α4β7、TL1A和IL-23的研究性延长半衰期抗体。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBD","SYRE","LENZ","BK4539","BK4007","NQmain"],"gpt_icon":0},{"id":"2570009184","title":"美國研究綜述-Carmax、Mirion Technologies、Valmont Industries","url":"https://stock-news.laohu8.com/highlight/detail?id=2570009184","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570009184?lang=zh_tw&edition=fundamental","pubTime":"2025-09-26 17:41","pubTimestamp":1758879719,"startTime":"0","endTime":"0","summary":"美国研究综述-Carmax、Mirion Technologies、Valmont Industries路透社9月26日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Carmax、Mirion Technologies 和 Valmont Industries。* First Horizon Corp FHN.N：D.A.戴维森给予该公司中性评级* Mirion Technologies Inc MIR.N：摩根大通给予增持评级* Riot Platforms Inc RIOT.O：摩根大通将其评级从中性上调至增持* Valmont Industries Inc VMI.N：摩根大通给予该公司增持评级以下是路透社周五报道的美国公司研究行动摘要。* Allarity Therapeutics ALLR.O：Ascendiant Capital Markets将其预测价格从9美元上调至9.25美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nL3S3VD0JX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LEVI","LU0648001328.SGD","LU0965509010.AUD","MIR","BK4139","LU0980610538.SGD","LU1934455863.HKD","SYRE","BK4202","LU2290526834.HKD","KMX","UTHR","THO","CGON","BK4099","CALM","FHN","SNX","LU0417517546.SGD","ALLR","RL","IE00B894F039.SGD","BK4170","LU0265550946.USD","KVYO","ROL","BK4551","BK4504","FRME","DAVE","BK4023","LU1861215975.USD","CRNX","IMRX","VMI","LU0868494708.USD","LU1923622291.USD","MCK","LU2237438978.USD","LU2125154778.USD","PSTG","LU0942090050.USD","GH"],"gpt_icon":1},{"id":"2570009182","title":"美國研究綜述-Carmax、Mirion Technologies、Valmont Industries","url":"https://stock-news.laohu8.com/highlight/detail?id=2570009182","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570009182?lang=zh_tw&edition=fundamental","pubTime":"2025-09-26 17:41","pubTimestamp":1758879719,"startTime":"0","endTime":"0","summary":"美国研究综述-Carmax、Mirion Technologies、Valmont Industries路透社9月26日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Carmax、Mirion Technologies 和 Valmont Industries。* First Horizon Corp FHN.N：D.A.戴维森给予该公司中性评级* Mirion Technologies Inc MIR.N：摩根大通给予增持评级* Riot Platforms Inc RIOT.O：摩根大通将其评级从中性上调至增持* Valmont Industries Inc VMI.N：摩根大通给予该公司增持评级以下是路透社周五报导的美国公司研究行动摘要。* Allarity Therapeutics ALLR.O：Ascendiant Capital Markets将其预测价格从9美元上调至9.25美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nL3T3VD0JX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","UTHR","MIR","IMRX","CGON","LU0742534661.SGD","BK4212","RL","DAVE","LU2168564495.EUR","ALLR","BK4155","LU0648001328.SGD","GH","CRNX","SNX","VMI","LU2168563687.JPY","FRME","PSTG","IE00B19Z9Z06.USD","LEVI","LU0689472784.USD","LU0048573561.USD","CALM","KMX","LU0256863811.USD","LU2089279066.USD","KVYO","LU1814569148.SGD","LU1037948897.HKD","MCK","LU2211817866.USD","SYRE","LU2125909759.SGD","ROL","LU0417517546.SGD","LU1201861249.SGD","IE00B5TLWC47.USD","FHN","THO","LU2125909916.SGD","IE00BLDYK493.USD","LU1066053197.SGD"],"gpt_icon":1},{"id":"1123290538","title":"Spyre Therapeutics在開創性2期Skyway籃式試驗中為首位患者給藥，Spy072成為首個在風濕性疾病中研究的抗Tl1a抗體","url":"https://stock-news.laohu8.com/highlight/detail?id=1123290538","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123290538?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 20:05","pubTimestamp":1757937901,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics在开创性2期Skyway篮式试验中为首位患者给药，Spy072成为首个在风湿性疾病中研究的抗Tl1a抗体","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SYRE"],"gpt_icon":0},{"id":"2558684897","title":"Spyre Therapeutics, Inc.2025財年第二財季實現淨利潤-36.72百萬美元，同比減少37.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558684897","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558684897?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 00:01","pubTimestamp":1754841699,"startTime":"0","endTime":"0","summary":"8月11日，Spyre Therapeutics, Inc.公布财报，公告显示公司2025财年第二财季净利润为-36.72百万美元，同比减少37.27%；其中营业收入为0.00美元，每股基本收益为-0.60美元。机构评级：截至2025年8月11日，当前有10家机构对Spyre Therapeutics, Inc.目标价做出预测，其中目标均价为53.90美元，其中最低目标价为21.00美元，最高目标价为71.00美元。Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程、合理的治疗组合和用于患者选择的精准医学方法来创造下一代炎症性肠病  产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000404a6de083c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000404a6de083c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SYRE"],"gpt_icon":0},{"id":"2549498705","title":"IBM推出新芯片和服務器，主打為業務運營簡化人工智能流程","url":"https://stock-news.laohu8.com/highlight/detail?id=2549498705","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549498705?lang=zh_tw&edition=fundamental","pubTime":"2025-07-08 19:00","pubTimestamp":1751972415,"startTime":"0","endTime":"0","summary":"路透旧金山7月8日 - 国际商业机器公司IBM.N周二宣布推出一系列新的资料中心芯片和服务器(服务器)，IBM表示，这些芯片和服务器将比竞争对手更节能，并且将简化在业务运营中推出人工智能的过程。IBM周二推出了新款Power11芯片，这是自2020年以来其“Power”系列芯片的首次重大更新。IBM计划在今年第四季度将Power11与去年推出的AI芯片Spyre整合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nL6S3T503O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["2NVD.UK","LU1430594728.SGD","SNVD.UK","LU2065171402.SGD","IE0004086264.USD","NVDX","LU0323591593.USD","LU2360032135.SGD","LU1280957306.USD","LU0494093205.USD","LU2242650005.HKD","LU2463028550.USD","LU0345768153.USD","LU2458330243.SGD","LU1069344957.HKD","LU1267930730.SGD","LU2491050071.SGD","BK4141","LU2491049909.HKD","LU1935043536.SGD","NVD","NVD2.UK","NVDS","LU1303367103.USD","SYRE","LU0820562030.AUD","NVDS.UK","LU0417517546.SGD","LU2361044949.HKD","LU0943347566.SGD","NVD3.UK","LU1551013342.USD","LU1366333091.USD","BK4579","LU0640476718.USD","NVDU","BK4515","3NVD.UK","LU0238689110.USD","NVDD","IE0005OL40V9.USD","NVDY","LU1791710400.SGD","NVIW.SI","IBM","LU2360107168.USD"],"gpt_icon":1},{"id":"2544265289","title":"美國研究綜述-美國航空公司、捷普公司、萊納公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2544265289","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544265289?lang=zh_tw&edition=fundamental","pubTime":"2025-06-18 16:01","pubTimestamp":1750233715,"startTime":"0","endTime":"0","summary":"美国研究综述-美国航空公司、捷普公司、莱纳公司路透6月18日 - 华尔街证券分析师周三调整了对美国航空、捷普和莱纳尔等几家美国上市公司的评级和目标价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nL4T3SL0JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0787776722.HKD","BK4145","BK4504","CAVA","HON","LEN","LU0314104364.USD","SRPT","LU0171293334.USD","BK4534","BK4588","GNW","LU0348735423.USD","IE00BJJMRZ35.SGD","BK4596","LU0572940350.SGD","LU0516422952.EUR","JBL","BK4602","HSBA.UK","LUV","SG9999014898.SGD","BK4539","FLUT","LU2114397693.USD","BK4206","BK4512","SYRE","BK4500","LU1169590202.USD","UAL","DAL","LU2091194634.USD","IE00BJT1NW94.SGD","AAL","BK4550","IE00B2B36J28.USD","LU0898667661.SGD","LU0572939691.SGD","LU0831103253.SGD","LU0052756011.USD","LU0588546209.SGD","LU1481107354.HKD","LU0516422440.USD","SGXZ81514606.USD","SG9999017495.SGD","BK4209","BK4008","BK4559"],"gpt_icon":1},{"id":"2536584729","title":"Spyre Therapeutics, Inc.2025財年第一財季實現淨利潤-36.09百萬美元，同比減少36.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536584729","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536584729?lang=zh_tw&edition=fundamental","pubTime":"2025-05-18 00:00","pubTimestamp":1747497657,"startTime":"0","endTime":"0","summary":"5月18日，Spyre Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为-36.09百万美元，同比减少36.65%；其中营业收入为0.00美元，每股基本收益为-0.60美元。机构评级：截至2025年5月18日，当前有9家机构对Spyre Therapeutics, Inc.目标价做出预测，其中目标均价为54.67美元，其中最低目标价为21.00美元，最高目标价为71.00美元。Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程、合理的治疗组合和用于患者选择的精准医学方法来创造下一代炎症性肠病  产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000535a6e2d95b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000535a6e2d95b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRE","LENZ"],"gpt_icon":0},{"id":"2536134579","title":"Spyre Therapeutics, Inc.盤中異動 股價大漲5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536134579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536134579?lang=zh_tw&edition=fundamental","pubTime":"2025-05-17 01:20","pubTimestamp":1747416052,"startTime":"0","endTime":"0","summary":"北京时间2025年05月17日01时20分，Spyre Therapeutics, Inc.股票出现异动，股价急速上涨5.12%。Spyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程、合理的治疗组合和用于患者选择的精准医学方法来创造下一代炎症性肠病  产品。IBD 是一种以胃肠道炎症为特征的慢性疾病，包括 UC 和 CD 两种主要疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517012052975bfcdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517012052975bfcdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4539","BK4007","SYRE"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}